Literature DB >> 18217625

Nanoparticles as nonviral gene delivery vectors.

Andrea Ragusa1, Isabel García, Soledad Penadés.   

Abstract

Gene therapy, as therapeutic treatment to genetic or acquired diseases, is attracting much interest in the research community, leading to noteworthy developments over the past two decades. Although this field is still dominated by viral vectors, nonviral vectors have recently received an ever increasing attention in order to overcome the safety problems of their viral counterpart. This review presents the biological aspects involved in the gene delivery process and explores the recent developments and achievements of nonviral gene carriers.

Mesh:

Year:  2007        PMID: 18217625     DOI: 10.1109/tnb.2007.908996

Source DB:  PubMed          Journal:  IEEE Trans Nanobioscience        ISSN: 1536-1241            Impact factor:   2.935


  14 in total

Review 1.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

Review 2.  Gold nanoparticles: From nanomedicine to nanosensing.

Authors:  Po C Chen; Sandra C Mwakwari; Adegboyega K Oyelere
Journal:  Nanotechnol Sci Appl       Date:  2008-11-02

3.  Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells.

Authors:  Lara Pickel; Takaya Matsuzuka; Chiyo Doi; Rie Ayuzawa; Dharmendra Kumar Maurya; Sheng-Xue Xie; Cory Berkland; Masaaki Tamura
Journal:  Cancer Biol Ther       Date:  2009-12-22       Impact factor: 4.742

Review 4.  Drug discovery and development for rare genetic disorders.

Authors:  Wei Sun; Wei Zheng; Anton Simeonov
Journal:  Am J Med Genet A       Date:  2017-07-21       Impact factor: 2.802

5.  Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth.

Authors:  Atsushi Kawabata; Abdulgader Baoum; Naomi Ohta; Stephanie Jacquez; Gwi-Moon Seo; Cory Berkland; Masaaki Tamura
Journal:  Cancer Res       Date:  2012-03-02       Impact factor: 12.701

6.  Polyethylenimine functionalized magnetic nanoparticles as a potential non-viral vector for gene delivery.

Authors:  Yangbo Zhou; Zhaomin Tang; Chunli Shi; Shuai Shi; Zhiyong Qian; Shaobing Zhou
Journal:  J Mater Sci Mater Med       Date:  2012-07-24       Impact factor: 3.896

7.  Size-uniform 200 nm particles: fabrication and application to magnetofection.

Authors:  Lamar Mair; Kris Ford; M d Rowshon Alam; Ryszard Kole; Michael Fisher; Richard Superfine
Journal:  J Biomed Nanotechnol       Date:  2009-04       Impact factor: 4.099

Review 8.  Transcriptional targeting of tumor endothelial cells for gene therapy.

Authors:  Zhihong Dong; Jacques E Nör
Journal:  Adv Drug Deliv Rev       Date:  2009-04-23       Impact factor: 15.470

9.  Gene therapy for type 1 diabetes mellitus in rats by gastrointestinal administration of chitosan nanoparticles containing human insulin gene.

Authors:  Li Niu; Yan-Cheng Xu; Zhe Dai; Hui-Qin Tang
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

10.  Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.

Authors:  Ajay Sharma; Ashish Tandon; Jonathan C K Tovey; Rangan Gupta; J David Robertson; Jennifer A Fortune; Alexander M Klibanov; John W Cowden; Frank G Rieger; Rajiv R Mohan
Journal:  Nanomedicine       Date:  2011-01-25       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.